Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

Popovic, Vera, Leal, Alfonso, Micic, Dragan, Koppeschaar, Hans PF, Torres, Elena, Paramo, Concha, Obradovic, Sandra, Dieguez, Carlos, Casanueva, Felipe F · 2000 · The Lancet

Abstract

Background The diagnosis of growth hormone (GH) deficiency in adults is based on provocative testing of GH secretion. The insulin tolerance test (ITT), currently the favoured test for this diagnosis, has been criticised for poor reproducibility and inconvenience. Since the combined administration of GH-releasing hormone (GHRH) plus GH-releasing peptide-6 (GHRP-6) is the most potent stimulus of GH secretion, we did a multicentre study comparing GH peaks elicited by ITT with those elicited by the GHRH/GHRP-6 test in healthy controls and GH-deficient individuals (cases). Methods 125 adult patients with organic pituitary disease and 125 healthy individuals were studied. All cases and controls were given GHRH 1 microg per kg bodyweight intravenously plus GHRP-6 1 microg per kg intravenously at 0 min and blood samples were obtained during a subsequent 120 min period. 27 controls and all cases had an ITT. Inclusion criteria were severe GH deficiency--ie, a GH peak after ITT of Findings GH peaks seen after the GHRH/GHRP-6 test did not result in any side-effects and were not affected by age, sex, amount of adipose tissue, or by the GH assay system used. The GH mean peak after the GHRH/GHRP-6 test was 59.2 microg/L (SD 2.2) for controls and 4.1 microg/L (0.3) for cases, whereas after ITT the mean peak was 14.3 microg/L (1.7) and 0.5 microg/L (0.06), respectively. The differential peak responses of controls and cases was greater (p or = 20.00 microg/L be considered normal and Interpreta…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(00)02755-0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. Popovic, 1995, J Clin Endocrinol Metab, 80, 942

Cited by

See all 185

Metadata

Authors
Popovic, V., Leal, A., Micic, D., Koppeschaar, H. P., Torres, E., Paramo, C., Obradovic, S., Dieguez, C., & Casanueva, F. F.
Affiliations
  • Hospital Universitario Virgen del Rocío (ES)
  • Universidade de Santiago de Compostela (ES)
Corresponding author
Casanueva, Felipe F
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-09
Volume
356
Issue
9236
Pages
1137-1142
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2155790795
Cited by
185
References
33
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 10 · 2014: 5 · 2013: 6 · 2012: 10
FWCI
9.29
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Xunta de Galicia
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
growth hormone deficiency, adults, growth hormone-releasing hormone, insulin tolerance test, provocation tests, diagnostic thresholds, pituitary disorders, receiver operating characteristic, test reproducibility, age and sex effects, adipose tissue
MeSH terms
Adolescent, Adult, Aged, Child, Female, Humans, Insulin, Male, Middle Aged, Oligopeptides, Pituitary Diseases, ROC Curve, Sensitivity and Specificity, Growth Hormone-Releasing Hormone, Body Mass Index, Case-Control Studies, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. https://app.cochat.ai/papers/10.1016/s0140-6736(00)02755-0
The paper
Popovic, V., Leal, A., Micic, D., Koppeschaar, H. P., Torres, E., Paramo, C., Obradovic, S., Dieguez, C., & Casanueva, F. F. (2000). GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. The Lancet. https://doi.org/10.1016/s0140-6736(00)02755-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.